Dry Eye Disease: Emerging Therapies

Dry eye disease (DED) is evolving with promising therapies aimed at alleviating symptoms and improving ocular surface health. Emerging treatments include novel lubricants, such as lipid-based formulations, which stabilize tear film and enhance moisture retention. Anti-inflammatory agents target underlying immune responses that contribute to chronic dryness and discomfort. Advanced technologies like intense pulsed light therapy and thermal pulsation systems offer non-invasive approaches to improve Meibomian gland function and alleviate evaporative dry eye. Furthermore, regenerative therapies utilizing growth factors and stem cells show potential for restoring damaged ocular tissues and promoting natural tear production. These innovations signal a hopeful future for managing DED more effectively and enhancing patients' quality of life.

    Related Conference of Dry Eye Disease: Emerging Therapies

    September 16-17, 2025

    20th International Conference on Ophthalmology and Vision Science

    Amsterdam, Netherlands
    September 22-23, 2025

    8th International Eye and Vision Congress

    Amsterdam, Netherlands
    October 20-21, 2025

    6th World Congress on Ophthalmology and Vision Science

    Barcelona, Spain
    November 03-04, 2025

    39th European Ophthalmology Congress

    Rome, Italy
    January 12-13, 2026

    26th Global Ophthalmologists Annual Meeting

    London, UK
    April 20-21, 2026

    3rd International Conference on Ophthalmology

    Barcelona, Spain
    May 07-08, 2026

    7th International Conference on Optometry

    Paris, France
    May 25-26, 2026

    10th World Congress on Eye and Vision

    Madrid, Spain

    Dry Eye Disease: Emerging Therapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in